CDC Telebriefing: New Vital Signs Report
Wide variation in naloxone prescribing and dispensing persists across the U.S.: What can pharmacists and other healthcare providers do to ensure naloxone is available when needed?

Media Advisory

Embargoed Until: Tuesday, August 6, 2019, 1:00 p.m. ET
Contact: Media Relations
(404) 639-3286

What

From 2017 to 2018, the number of high-dose opioid prescriptions decreased and naloxone prescriptions increased. However, despite progress, only one naloxone prescription was dispensed for every 70 high-dose opioid prescriptions nationwide.

Who

Anne Schuchat, MD, Principal Deputy Director, CDC

Gery Guy, Lead Author of Study and Economist, National Center for Injury Prevention and Control (NCIPC)

When

Tuesday, August 6, at 12:00 p.m. ET

Dial-In  

Media: 888-795-0855
Non-Media: 800-369-1605
INTERNATIONAL: 1-630-395-0331
PASSCODE: CDC Media

Important Instructions
If you would like to ask a question during the call, press *1 on your touchtone phone. Press *2 to withdraw your question.

You may queue up at any time. You will hear a tone to indicate your question is pending.

TRANSCRIPT
A transcript will be available following the briefing at CDC’s web site: www.cdc.gov/media.

###
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICESexternal icon

CDC works 24/7 protecting America’s health, safety and security. Whether disease start at home or abroad, are curable or preventable, chronic or acute, or from human activity or deliberate attack, CDC responds to America’s most pressing health threats. CDC is headquartered in Atlanta and has experts located throughout the United States and the world.

Page last reviewed: August 6, 2019